MeSH term
Frequency | Condition_Probility | Cell Nucleus/*metabolism | 4 | 0.0 |
Hela Cells | 7 | 0.0 |
Humans | 35 | 0.0 |
Lamins | 2 | 3.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 19 | 0.0 |
Animals | 15 | 0.0 |
Cell Line | 7 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Interphase | 2 | 1.0 |
Luminescent Proteins/metabolism | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Rats | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
ran GTP-Binding Protein/metabolism | 2 | 10.0 |
Dimerization | 2 | 0.0 |
Microscopy, Fluorescence | 6 | 0.0 |
Microscopy, Immunoelectron | 5 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 2 | 1.0 |
Transfection | 4 | 0.0 |
Female | 12 | 0.0 |
Karyopherins | 2 | 7.0 |
*Nuclear Pore Complex Proteins | 3 | 4.0 |
Amino Acid Sequence | 5 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Mutation | 2 | 0.0 |
Adult | 12 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Male | 16 | 0.0 |
Middle Aged | 7 | 0.0 |
Models, Biological | 6 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Mice | 4 | 0.0 |
Models, Molecular | 2 | 0.0 |
Hemodynamic Processes/*physiology | 2 | 6.0 |
Hamsters | 2 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
English Abstract | 3 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Biological Transport | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Nuclear Proteins/chemistry/*physiology | 2 | 10.0 |
Structure-Activity Relationship | 2 | 0.0 |
Nuclear Envelope/metabolism | 2 | 6.0 |
DNA, Complementary | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Swine | 2 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Exercise/*physiology | 2 | 0.0 |
United States | 2 | 0.0 |
*Pulmonary Circulation | 2 | 16.0 |
*Hemodynamic Processes | 3 | 6.0 |
*Altitude | 2 | 3.0 |
*Blood Pressure | 2 | 1.0 |
Chromosome Mapping | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
Drug Resistance, Microbial | 2 | 1.0 |
Trimethoprim/*pharmacology | 2 | 16.0 |
Cardiac Output | 2 | 4.0 |
Vascular Resistance | 2 | 3.0 |
